Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


1 Am J Physiol Lung Cell Mol Physiol
1 Ann Transl Med
1 Arch Cardiovasc Dis
2 Biol Aujourdhui
1 Biomed Pharmacother
1 Curr Gastroenterol Rep
1 Eur J Heart Fail
1 G Ital Cardiol (Rome)
1 Hypertens Res
1 J Heart Lung Transplant
1 JCI Insight
1 Medicine (Baltimore)
1 Nihon Yakurigaku Zasshi
1 Pediatr Cardiol
1 Pediatr Pulmonol
1 PLoS One
1 Ter Arkh
1 Thromb Haemost

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Physiol Lung Cell Mol Physiol

  1. ADESINA SE, Wade BE, Bijli KM, Kang BY, et al
    Hypoxia Inhibits Expression and Function of Mitochondrial Thioredoxin 2 to Promote Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2017 Jan 27:ajplung.00258.2016.
    PubMed     Text format     Abstract available

    Ann Transl Med

  2. KIM MJ, Jung HO
    Pulmonary hypertension: a long-term risk stratifier in primary mitral regurgitation.
    Ann Transl Med. 2016;4:541.
    PubMed     Text format    

    Arch Cardiovasc Dis

  3. SANTOS-RIBEIRO D, Mendes-Ferreira P, Maia-Rocha C, Adao R, et al
    Pulmonary arterial hypertension: Basic knowledge for clinicians.
    Arch Cardiovasc Dis. 2016;109:550-561.
    PubMed     Text format     Abstract available

    Biol Aujourdhui

  4. TU L, Ghigna MR, Phan C, Bordenave J, et al
    [Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications].
    Biol Aujourdhui. 2016;210:65-78.
    PubMed     Text format     Abstract available

  5. AYME-DIETRICH E, Banas SM, Monassier L, Maroteaux L, et al
    [Pulmonary arterial hypertension, bone marrow, endothelial cell precursors and serotonin].
    Biol Aujourdhui. 2016;210:79-88.
    PubMed     Text format     Abstract available

    Biomed Pharmacother

  6. CHEN H, Yang H, Xu C, Yue H, et al
    Gene expression profiling of common signal transduction pathways affected by rBMSCs/F92A-Cav1 in the lungs of rat with pulmonary arterial hypertension.
    Biomed Pharmacother. 2016;83:100-106.
    PubMed     Text format     Abstract available

    Curr Gastroenterol Rep

  7. FUSSNER LA, Krowka MJ
    Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.
    Curr Gastroenterol Rep. 2016;18:29.
    PubMed     Text format     Abstract available

    Eur J Heart Fail

    Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format    

    G Ital Cardiol (Rome)

    [European guidelines on the management of pulmonary hypertension: what's new?]
    G Ital Cardiol (Rome). 2016;17:954-958.
    PubMed     Text format    

    Hypertens Res

  10. XU YP, He Q, Shen Z, Shu XL, et al
    MiR-126a-5p is involved in the hypoxia-induced endothelial-to-mesenchymal transition of neonatal pulmonary hypertension.
    Hypertens Res. 2017 Feb 2. doi: 10.1038/hr.2017.
    PubMed     Text format     Abstract available

    J Heart Lung Transplant

  11. CARAVITA S, Faini A, Deboeck G, Bondue A, et al
    Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component.
    J Heart Lung Transplant. 2016 Dec 23. pii: S1053-2498(16)30471.
    PubMed     Text format     Abstract available

    JCI Insight

  12. CHEN PI, Cao A, Miyagawa K, Tojais NF, et al
    Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension.
    JCI Insight. 2017;2:e90427.
    PubMed     Text format     Abstract available

    Medicine (Baltimore)

  13. PEROSA F, Favoino E, Favia IE, Vettori S, et al
    Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.
    Medicine (Baltimore). 2016;95:e3931.
    PubMed     Text format     Abstract available

    Nihon Yakurigaku Zasshi

  14. HORINOUCHI T, Mazaki Y, Terada K, Higashi T, et al
    Current progress in therapeutic agents for pulmonary arterial hypertension: new insights into their mechanisms of action from endothelin system.
    Nihon Yakurigaku Zasshi. 2016;148:231-238.
    PubMed     Text format    

    Pediatr Cardiol

  15. LI G, Tang L, Jia P, Zhao J, et al
    Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Pediatr Cardiol. 2016;37:714-21.
    PubMed     Text format     Abstract available

    Pediatr Pulmonol

  16. MAHGOUB L, Kaddoura T, Kameny AR, Lopez Ortego P, et al
    Pulmonary vein stenosis of ex-premature infants with pulmonary hypertension and bronchopulmonary dysplasia, epidemiology, and survival from a multicenter cohort.
    Pediatr Pulmonol. 2017 Feb 2. doi: 10.1002/ppul.23679.
    PubMed     Text format     Abstract available

    PLoS One

  17. HIMORI K, Abe M, Tatebayashi D, Lee J, et al
    Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension.
    PLoS One. 2017;12:e0169146.
    PubMed     Text format     Abstract available

    Ter Arkh

  18. ARKHIPOVA OA, Martynyuk TV, Chazova IE
    [A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension].
    Ter Arkh. 2016;88:88-93.
    PubMed     Text format     Abstract available

    Thromb Haemost

  19. BOCHENEK ML, Rosinus NS, Lankeit M, Hobohm L, et al
    From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-10-0790.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.